Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.315 EUR -1.1% Market Closed
Market Cap: 36.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gensight Biologics SA
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Effect of Foreign Exchange Rates
€63k
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Effect of Foreign Exchange Rates
-€391k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Effect of Foreign Exchange Rates
€57k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inventiva SA
PAR:IVA
Effect of Foreign Exchange Rates
€947k
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Effect of Foreign Exchange Rates
€147k
CAGR 3-Years
319%
CAGR 5-Years
60%
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Gensight Biologics SA
Glance View

Market Cap
36.3m EUR
Industry
Biotechnology

GenSight Biologics SA is a clinical-stage gene therapy company. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2016-07-13. The firm develops and commercializes gene therapy-based treatments of retinal degenerative diseases. The company develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The firm intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).

SIGHT Intrinsic Value
0.171 EUR
Overvaluation 46%
Intrinsic Value
Price

See Also

What is Gensight Biologics SA's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
63k EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Effect of Foreign Exchange Rates amounts to 63k EUR.

What is Gensight Biologics SA's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
-27%

Over the last year, the Effect of Foreign Exchange Rates growth was -61%. The average annual Effect of Foreign Exchange Rates growth rates for Gensight Biologics SA have been -27% over the past three years .

Back to Top